EMPROS PHARMA AB has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, Mexico and United States. Its main competitors in its focus markets pharmaceuticals are OSMOTICA COSTA RICA SA, LIFE WELL LIVED LLC and N C PHARM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 2 | |
#2 | Mexico | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Chile | 1 | |
#8 | China | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | EPO (European Patent Office) | 1 | |
#11 | Israel | 1 | |
#12 | New Zealand | 1 | |
#13 | Peru | 1 | |
#14 | Philippines | 1 | |
#15 | Singapore | 1 | |
#16 | Ukraine | 1 | |
#17 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Forslund Anders | 16 |
#2 | Gruden Jan Stefan Persson | 9 |
#3 | Lennernäs Hans | 7 |
#4 | Grudén Jan Stefan Persson | 7 |
#5 | Alderborn Göran | 7 |
#6 | Holmbäck Ulf | 7 |
#7 | Holmback Ulf | 5 |
#8 | Lennernas Hans | 5 |
#9 | Alderborn Goeran | 4 |
#10 | Anders Forslund | 4 |
Publication | Filing date | Title |
---|---|---|
CN107405309A | The tune of orlistat and acarbose for treating obesity and related metabolic disturbance releases composition |